vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and HALOZYME THERAPEUTICS, INC. (HALO). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $351.4M, roughly 1.3× APOGEE ENTERPRISES, INC.). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs -31.3%, a 36.1% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 1.6%). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 2.9%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
APOG vs HALO — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $451.8M |
| Net Profit | $16.6M | $-141.6M |
| Gross Margin | 22.4% | 82.6% |
| Operating Margin | 7.3% | -20.6% |
| Net Margin | 4.7% | -31.3% |
| Revenue YoY | 1.6% | 51.6% |
| Net Profit YoY | 568.8% | -203.3% |
| EPS (diluted) | $0.78 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $451.8M | ||
| Q3 25 | $358.2M | $354.3M | ||
| Q2 25 | $346.6M | $325.7M | ||
| Q1 25 | $345.7M | $264.9M | ||
| Q4 24 | $341.3M | $298.0M | ||
| Q3 24 | $342.4M | $290.1M | ||
| Q2 24 | $331.5M | $231.4M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-141.6M | ||
| Q3 25 | $23.6M | $175.2M | ||
| Q2 25 | $-2.7M | $165.2M | ||
| Q1 25 | $2.5M | $118.1M | ||
| Q4 24 | $21.0M | $137.0M | ||
| Q3 24 | $30.6M | $137.0M | ||
| Q2 24 | $31.0M | $93.2M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 82.6% | ||
| Q3 25 | 23.1% | 84.4% | ||
| Q2 25 | 21.7% | 85.8% | ||
| Q1 25 | 21.6% | 81.7% | ||
| Q4 24 | 26.1% | 85.9% | ||
| Q3 24 | 28.4% | 83.0% | ||
| Q2 24 | 29.8% | 82.9% |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | -20.6% | ||
| Q3 25 | 7.5% | 61.5% | ||
| Q2 25 | 2.0% | 62.2% | ||
| Q1 25 | 1.8% | 53.4% | ||
| Q4 24 | 8.4% | 58.9% | ||
| Q3 24 | 12.3% | 56.3% | ||
| Q2 24 | 12.5% | 50.7% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -31.3% | ||
| Q3 25 | 6.6% | 49.5% | ||
| Q2 25 | -0.8% | 50.7% | ||
| Q1 25 | 0.7% | 44.6% | ||
| Q4 24 | 6.1% | 46.0% | ||
| Q3 24 | 8.9% | 47.2% | ||
| Q2 24 | 9.4% | 40.3% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-1.13 | ||
| Q3 25 | $1.10 | $1.43 | ||
| Q2 25 | $-0.13 | $1.33 | ||
| Q1 25 | $0.12 | $0.93 | ||
| Q4 24 | $0.96 | $1.06 | ||
| Q3 24 | $1.40 | $1.05 | ||
| Q2 24 | $1.41 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $133.8M |
| Total DebtLower is stronger | $232.3M | $2.1B |
| Stockholders' EquityBook value | $511.8M | $48.8M |
| Total Assets | $1.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.45× | 43.89× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $133.8M | ||
| Q3 25 | $39.5M | $419.7M | ||
| Q2 25 | $32.8M | $61.9M | ||
| Q1 25 | $41.4M | $176.3M | ||
| Q4 24 | $43.9M | $115.8M | ||
| Q3 24 | $51.0M | $154.3M | ||
| Q2 24 | $30.4M | $187.9M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | $285.0M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $48.8M | ||
| Q3 25 | $500.2M | $503.9M | ||
| Q2 25 | $481.8M | $332.7M | ||
| Q1 25 | $487.9M | $482.3M | ||
| Q4 24 | $522.1M | $363.8M | ||
| Q3 24 | $506.4M | $452.7M | ||
| Q2 24 | $480.0M | $289.4M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.2B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $917.1M | $2.1B | ||
| Q2 24 | $889.0M | $2.0B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 43.89× | ||
| Q3 25 | — | 3.00× | ||
| Q2 25 | — | 4.54× | ||
| Q1 25 | 0.58× | 3.13× | ||
| Q4 24 | — | 4.14× | ||
| Q3 24 | — | 3.32× | ||
| Q2 24 | — | 5.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | $219.0M |
| Free Cash FlowOCF − Capex | — | $217.6M |
| FCF MarginFCF / Revenue | — | 48.2% |
| Capex IntensityCapex / Revenue | 7.8% | 0.3% |
| Cash ConversionOCF / Net Profit | 7.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $644.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $219.0M | ||
| Q3 25 | $57.1M | $178.6M | ||
| Q2 25 | $-19.8M | $99.7M | ||
| Q1 25 | $30.0M | $154.2M | ||
| Q4 24 | $31.0M | $178.5M | ||
| Q3 24 | $58.7M | $115.4M | ||
| Q2 24 | $5.5M | $55.8M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $217.6M | ||
| Q3 25 | $52.4M | $175.6M | ||
| Q2 25 | $-26.9M | $98.1M | ||
| Q1 25 | $19.1M | $153.3M | ||
| Q4 24 | $22.0M | $175.4M | ||
| Q3 24 | $50.2M | $113.9M | ||
| Q2 24 | $-1.8M | $53.2M |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 48.2% | ||
| Q3 25 | 14.6% | 49.6% | ||
| Q2 25 | -7.8% | 30.1% | ||
| Q1 25 | 5.5% | 57.9% | ||
| Q4 24 | 6.4% | 58.9% | ||
| Q3 24 | 14.7% | 39.3% | ||
| Q2 24 | -0.5% | 23.0% |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 2.1% | 0.5% | ||
| Q1 25 | 3.2% | 0.4% | ||
| Q4 24 | 2.6% | 1.0% | ||
| Q3 24 | 2.5% | 0.5% | ||
| Q2 24 | 2.2% | 1.1% |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | 1.02× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | 12.08× | 1.31× | ||
| Q4 24 | 1.48× | 1.30× | ||
| Q3 24 | 1.92× | 0.84× | ||
| Q2 24 | 0.18× | 0.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
